Abstract:With the continuous development of imaging technology and nanotechnology, it is expected to further make in‐depth study on tumor‐associated bacteria and develop new bacterial imaging methods for tumor diagnosis. Some bacteria, such as Escherichia coli (E. coli) and Salmonella typhimurium (S. typhimurium), have an inherent ability to locate solid tumours, making them a versatile platform that can be combined with other tools to improve the tumour diagnosis and treatment. In anti‐cancer therapy, bacteria function by carrying drugs directly or expressing exogenous therapeutic genes. The application of bacterial imaging in tumour diagnosis, a novel and promising research area, can indeed provide dynamic and real‐time monitoring in both pre‐treatment assessment and post‐treatment detection. Different imaging techniques, including optical technology, acoustic imaging, magnetic resonance imaging (MRI) and nuclear medicine imaging, allow us to observe and track tumour‐associated bacteria. Optical imaging, including bioluminescence and fluorescence, provides high‐sensitivity and high‐resolution imaging. Acoustic imaging is a real‐time and non‐invasive imaging technique with good penetration depth and spatial resolution. MRI provides high spatial resolution and radiation‐free imaging. Nuclear medicine imaging, including positron emission tomography (PET) and single photon emission computed tomography (SPECT) can provide information on the distribution and dynamics of bacterial population. Moreover, strategies of synthetic biology modification and nanomaterial engineering modification can improve the viability and localization ability of bacteria while maintaining their autonomy and vitality, thus aiding the visualization of gut bacteria. However, there are some challenges, such as the relatively low bacterial abundance and heterogeneously distribution within the tumour, the high dimensionality of spatial datasets and the limitations of imaging labeling tools. In summary, with the continuous development of imaging technology and nanotechnology, it is expected to further make in‐depth study on tumour‐associated bacteria and develop new bacterial imaging methods for tumour diagnosis.

Real-time imaging of tumors using replication-competent light-emitting microorganisms.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Bacteria-Based Live Vehicle for In Vivo Bioluminescence Imaging

Microbial-based cancer therapy-bugs as drugs: History & the essential role of medical imaging.

Visualization of GFP-expressing tumors and metastasis in vivo

Bioluminescent Bacterial Imaging in Vivo

Upconversion Optogenetic Engineered Bacteria System for Time-Resolved Imaging Diagnosis and Light-Controlled Cancer Therapy

Genetically engineered probiotics for an optical imaging-guided tumor photothermal therapy/immunotherapy

Intravital Fluorescence Facilitates Measurement of Multiple Physiologic Functions and Gene Expression in Tumors of Live Animals

Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models

Bacterial imaging in tumour diagnosis

Real-time pathology through in vivo microscopy

Non-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence Protein

Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria

Fluorescence Nanoprobe Imaging Tumor By Sensing The Acidic Microenvironment

Engineered Microorganisms for Advancing Tumor Therapy

Engineered Oncolytic Bacteria for Malignant Solid Tumor Treatment

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution

Advancements of engineered live oncolytic biotherapeutics (microbe/virus/cells): Preclinical research and clinical progress

Evaluation of nanoparticle uptake in tumors in real time using intravital imaging

Ultrasound-controllable engineered bacteria for cancer immunotherapy